A device component that will touch skin, tissue, or bodily fluids cannot be bonded with an adhesive chosen on strength alone — the cured chemistry itself has to be proven safe for that contact, and “proven” means a specific, auditable body of test data.

What Makes an Epoxy “Biocompatible”

A standard two-part industrial epoxy is formulated purely for mechanical and chemical performance — bond strength, cure speed, resistance to solvents and heat. Nothing in that formulation process screens for leachable byproducts, residual monomer, or cured-resin extractables that could provoke a toxic, inflammatory, or allergenic response in living tissue. A biocompatible epoxy starts from the same resin-and-hardener chemistry but is reformulated and tested specifically to eliminate those risks — lower-extractable curing agents, tighter control over unreacted components, and validation against recognized biological safety standards before it’s ever cleared for device-contact use.

The distinction matters because “medical grade” is not a formulation category a supplier can claim informally. It has to be backed by test reports tied to a specific standard, a specific test battery, and a specific cured-state sample — not the raw resin.

The Standards That Actually Define It

Two frameworks anchor nearly every biocompatibility claim in device manufacturing:

• ISO 10993-5 (cytotoxicity): Evaluates whether extractables from the cured material kill or damage living cells in vitro. This is the baseline test almost every device-contact adhesive is run against, and it’s specific to the cured polymer, not the liquid components.
• ISO 10993-10 (sensitization and irritation): Screens for allergenic or irritant response from skin or mucosal contact, relevant for any component with intended external or transient patient contact.

A supplier quoting “USP Class VI” alongside ISO 10993 data is referencing an older, narrower U.S. Pharmacopeia in-vivo test set (systemic toxicity, intracutaneous reactivity); it’s still cited in some legacy specs but has largely been supplemented by the ISO 10993 series in current device-development programs. Either way, request the underlying report, not just the pass/fail claim — the same generic phrase gets used loosely in marketing copy that has no test data behind it at all.

Where This Chemistry Actually Gets Used

Formulated correctly, biocompatible epoxies see real use in external and disposable device-component work: diagnostic cartridge housings, external wearable-sensor enclosures, connector and hub bonding on single-use fluid-path assemblies, and structural bonding inside benchtop lab and point-of-care instrumentation that never enters the body itself. These are lower-risk, shorter-duration-contact applications where a cytotoxicity-clean epoxy bond is the deciding factor, not an implant-grade, lifetime-stability claim — that’s a substantially higher bar with its own separate standard set and is outside the scope of a general adhesive-selection decision.

Email Us if your project needs help mapping a bonding requirement to the right documentation trail before your regulatory submission is due — waiting until late in development to confirm an adhesive’s test data is one of the more common causes of schedule slip in device programs.

Practical Steps Before You Specify One

Three things should happen before a biocompatible epoxy gets locked into a bill of materials. First, define the actual contact profile — duration, tissue or fluid type, and whether it’s direct or indirect — since that changes which test battery applies. Second, request the full test report tied to the cured resin, not a generic compliance letter. Third, remember that certifying the raw adhesive is not the same as certifying the finished device: sterilization method, mixed-material interactions, and processing residues can all shift the biological response of the completed assembly, so final-device testing stays mandatory even with fully documented component-level data in hand.

Handling Considerations That Affect the Final Bond

Biocompatible epoxies typically run as two-part systems with tighter mix-ratio tolerances than general-industrial grades, because an off-ratio cure changes the extractable profile the biocompatibility data was based on. A shop moving a device-assembly line from manual mixing to metered dispensing should re-verify cure completeness on the new equipment rather than assume the original test data still applies — dispense-tip residence time, mix-head geometry, and ambient cure temperature all influence how fully the resin cross-links, and an incompletely cured bond line can leave uncured monomer behind even when the base formulation passed cytotoxicity testing. Substrate compatibility deserves the same scrutiny: most biocompatible epoxies bond well to stainless steel, glass, and common engineering plastics like polycarbonate and ABS, but low-surface-energy materials such as PTFE or silicone still need surface treatment (plasma, corona, or a compatible primer) regardless of the adhesive’s biological rating. Skipping that step is a mechanical-bond-failure risk independent of biocompatibility, and it’s one of the more frequent root causes when a certified adhesive still fails in a finished assembly.

This is also where bond-strength engineering can’t be an afterthought — a biocompatible formulation that’s mechanically undersized for its joint will fail regardless of its cytotoxicity rating, and how CTE mismatch drives long-term bond failure is worth understanding for any rigid epoxy bonded across dissimilar substrates. For a broader look at where epoxy outperforms faster-curing chemistries on structural applications generally, see UV glue vs. epoxy for heavy-duty repairs.

Incure manufactures adhesives across epoxy, cyanoacrylate, and UV-cure chemistries for industrial and device-assembly manufacturers, including formulations developed toward ISO 10993-5 compliance for external and disposable-device applications. If you’re evaluating options for a specific component, Contact Our Team to discuss which chemistry and documentation package fits your project’s contact profile and regulatory timeline.

Visit www.incurelab.com for more information.